Gene May Undermine Tamoxifen's Effectiveness (HealthDay)


HealthDay - MONDAY, Dec. 19 (HealthDay News) -- A common gene mutation may render the cancer-preventing drug tamoxifen less effective in preventing tumor recurrence in some breast cancer survivors, a new study suggests.